Cargando…

Long-Term Antitumor CD8(+) T Cell Immunity Induced by Endogenously Engineered Extracellular Vesicles

SIMPLE SUMMARY: The induction of an effective immune response against tumor cells is of a great benefit in the battle against cancers. We recently characterized a novel, safe, and cost-effective strategy to induce an efficient CD8(+) T cell immune response against potentially whatever antigen. This...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferrantelli, Flavia, Manfredi, Francesco, Chiozzini, Chiara, Leone, Patrizia, Giovannelli, Andrea, Olivetta, Eleonora, Federico, Maurizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125873/ https://www.ncbi.nlm.nih.gov/pubmed/34066801 http://dx.doi.org/10.3390/cancers13092263

Ejemplares similares

The C-Terminal Domain of Nef(mut) Is Dispensable for the CD8(+) T Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles
por: Chiozzini, Chiara, et al.
Publicado: (2021)

Simultaneous CD8(+) T-Cell Immune Response against SARS-Cov-2 S, M, and N Induced by Endogenously Engineered Extracellular Vesicles in Both Spleen and Lungs
por: Ferrantelli, Flavia, et al.
Publicado: (2021)

N-Terminal Fatty Acids of NEF(MUT) Are Required for the CD8(+) T-Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles
por: Chiozzini, Chiara, et al.
Publicado: (2020)

Activation of Anti-SARS-CoV-2 Human CTLs by Extracellular Vesicles Engineered with the N Viral Protein
por: Manfredi, Francesco, et al.
Publicado: (2022)

Engineered Extracellular Vesicles/Exosomes as a New Tool against Neurodegenerative Diseases
por: Ferrantelli, Flavia, et al.
Publicado: (2020)

Strong SARS-CoV-2 N-Specific CD8(+) T Immunity Induced by Engineered Extracellular Vesicles Associates with Protection from Lethal Infection in Mice
por: Ferrantelli, Flavia, et al.
Publicado: (2022)

The Intracellular Delivery Of Anti-HPV16 E7 scFvs Through Engineered Extracellular Vesicles Inhibits The Proliferation Of HPV-Infected Cells
por: Ferrantelli, Flavia, et al.
Publicado: (2019)

Antiviral effect of SARS-CoV-2 N-specific CD8(+) T cells induced in lungs by engineered extracellular vesicles
por: Manfredi, Francesco, et al.
Publicado: (2023)

Antitumor HPV E7-specific CTL activity elicited by in vivo engineered exosomes produced through DNA inoculation
por: Di Bonito, Paola, et al.
Publicado: (2017)

SARS-CoV-2-Specific CD8(+) T-Cells in Blood but Not in the Lungs of Vaccinated K18-hACE2 Mice after Infection
por: Ferrantelli, Flavia, et al.
Publicado: (2023)

Latent HIV-1 is activated by exosomes from cells infected with either replication-competent or defective HIV-1
por: Arenaccio, Claudia, et al.
Publicado: (2015)

HPV-E7 Delivered by Engineered Exosomes Elicits a Protective CD8(+) T Cell-Mediated Immune Response
por: Di Bonito, Paola, et al.
Publicado: (2015)

Exploiting Manipulated Small Extracellular Vesicles to Subvert Immunosuppression at the Tumor Microenvironment through Mannose Receptor/CD206 Targeting
por: Fiani, Maria Luisa, et al.
Publicado: (2020)

HIV-1 Nef Impairs Key Functional Activities in Human Macrophages through CD36 Downregulation
por: Olivetta, Eleonora, et al.
Publicado: (2014)

The CD8(+) T Cell-Mediated Immunity Induced by HPV-E6 Uploaded in Engineered Exosomes Is Improved by ISCOMATRIX(TM) Adjuvant
por: Manfredi, Francesco, et al.
Publicado: (2016)

Cell activation and HIV-1 replication in unstimulated CD4(+) T lymphocytes ingesting exosomes from cells expressing defective HIV-1
por: Arenaccio, Claudia, et al.
Publicado: (2014)

Plant hairy roots for the production of extracellular vesicles with antitumor bioactivity
por: Boccia, Eleonora, et al.
Publicado: (2022)

Anti-Cancer Vaccine for HPV-Associated Neoplasms: Focus on a Therapeutic HPV Vaccine Based on a Novel Tumor Antigen Delivery Method Using Endogenously Engineered Exosomes
por: Di Bonito, Paola, et al.
Publicado: (2019)

Identification of scaffold proteins for improved endogenous engineering of extracellular vesicles
por: Zheng, Wenyi, et al.
Publicado: (2023)

Bladder Cancer Extracellular Vesicles Elicit a CD8 T Cell-Mediated Antitumor Immunity
por: Ortiz-Bonilla, Carlos J., et al.
Publicado: (2022)

Antitumor synergism between PAK4 silencing and immunogenic phototherapy of engineered extracellular vesicles
por: Lu, Mei, et al.
Publicado: (2023)

Strategies for Engineering of Extracellular Vesicles
por: Danilushkina, Anna A., et al.
Publicado: (2023)

Extracellular Vesicles from Akkermansia muciniphila Elicit Antitumor Immunity Against Prostate Cancer via Modulation of CD8(+) T Cells and Macrophages
por: Luo, Zhong-Wei, et al.
Publicado: (2021)

Therapeutic Potential of Engineered Extracellular Vesicles
por: Mentkowski, Kyle I., et al.
Publicado: (2018)

Emerging technologies for engineering of extracellular vesicles
por: Zhou, Xin, et al.
Publicado: (2023)

RIG-I activation induces the release of extracellular vesicles with antitumor activity
por: Daßler-Plenker, Juliane, et al.
Publicado: (2016)

Murine Leukemia-Derived Extracellular Vesicles Elicit Antitumor Immune Response
por: Pando, Alejandro, et al.
Publicado: (2021)

The Role of Cancer Stem Cells and Their Extracellular Vesicles in the Modulation of the Antitumor Immunity
por: Chulpanova, Daria S., et al.
Publicado: (2022)

In Vivo Characterization of Endogenous Cardiovascular Extracellular Vesicles in Larval and Adult Zebrafish
por: Scott, Aaron, et al.
Publicado: (2021)

Engineering Extracellular Vesicles as Nanotherapeutics for Regenerative Medicine
por: Ramasubramanian, Lalithasri, et al.
Publicado: (2019)

Native and engineered extracellular vesicles for wound healing
por: Lu, Shengli, et al.
Publicado: (2022)

Surface-Engineered Extracellular Vesicles in Cancer Immunotherapy
por: Johnson, Vinith, et al.
Publicado: (2023)

Editorial: Engineered extracellular vesicles for tissue repairing
por: Yu, Shiyi, et al.
Publicado: (2023)

Engineered extracellular vesicles for ischemic stroke treatment
por: Ruan, Huitong, et al.
Publicado: (2023)

Harnessing allogeneic CD4(+) T cells to reinvigorate host endogenous antitumor immunity
por: Mochizuki, Kazuhiro
Publicado: (2023)

Improved Loading of Plasma-Derived Extracellular Vesicles to Encapsulate Antitumor miRNAs
por: Pomatto, Margherita Alba Carlotta, et al.
Publicado: (2019)

Triggering Endogenous Cardiac Repair and Regeneration via Extracellular Vesicle-Mediated Communication
por: Bollini, Sveva, et al.
Publicado: (2018)

Extracellular Vesicles: New Endogenous Shuttles for miRNAs in Cancer Diagnosis and Therapy?
por: Martellucci, Stefano, et al.
Publicado: (2020)

Charge-based precipitation of extracellular vesicles
por: Deregibus, Maria Chiara, et al.
Publicado: (2016)

CD103(+) cDC1 and endogenous CD8(+) T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor function
por: Kuhn, Nicholas F., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p17ctgvn6lledv89hbmvp6fv33